Date of Abstract presentation 9th December 2023 Indications Large B-cell lymphoma (LBCL) Abstract Number 105 Abstract type Oral For those patients with large B-cell lymphoma (LBCL) who remain uncured following initial treatment, the conventional approach for second-line therapy has been the utilization of high-dose chemotherapy (HDCT) and hematopoietic stem cell transplantation (HSCT). The PILOT study … Continue reading Liso-cel (lisocabtagene maraleucel) Shines in Second-Line, Yielding Long-Lasting Complete Responses for Non-Transplant Eligible LBCL Patients